in immunological assays. Clin Chem. 1999 Jul;45(7):942-56. \[[PubMed: 10388468](https://pubmed.ncbi.nlm.nih.gov/10388468)\] 85. Kricka LJ, Schmerfeld-Pruss D, Senior M, Goodman DB, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem. 1990 Jun;36(6):892-4. \[[PubMed: 2192822](https://pubmed.ncbi.nlm.nih.gov/2192822)\] 86. Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013 Oct;27(5):647-61. \[[PubMed: 24094636](https://pubmed.ncbi.nlm.nih.gov/24094636)\] 87. Klee GG. Human anti-mouse antibodies. Arch Pathol Lab Med. 2000 Jun;124(6):921-3. \[[PubMed: 10835540](https://pubmed.ncbi.nlm.nih.gov/10835540)\] 88. Chaulin AM. False-Positive Causes in Serum Cardiac Troponin Levels. J Clin Med Res. 2022 Feb;14(2):80-87. \[[PMC free article: PMC8912997](/pmc/articles/PMC8912997/)\] \[[PubMed: 35317362](https://pubmed.ncbi.nlm.nih.gov/35317362)\] 89. Ghazal K, Brabant S, Prie D, Piketty ML. Hormone Immunoassay Interference: A 2021 Update. Ann Lab Med. 2022 Jan 01;42(1):3-23. \[[PMC free article: PMC8368230](/pmc/articles/PMC8368230/)\] \[[PubMed: 34374345](https://pubmed.ncbi.nlm.nih.gov/34374345)\] 90. Warade J. Retrospective Approach to Evaluate Interferences in Immunoassay. EJIFCC. 2017 Oct;28(3):224-232. \[[PMC free article: PMC5655638](/pmc/articles/PMC5655638/)\] \[[PubMed: 29075172](https://pubmed.ncbi.nlm.nih.gov/29075172)\] 91. Van Der Vekens N, van Dievoet MA, De Puydt H, Decloedt A, Ven S, De Clercq D, Deprez P, van Loon G. Analytical validation of a high-sensitivity cardiac troponin T assay in horses. J Vet Diagn Invest. 2015 Jul;27(4):504-9. \[[PubMed: 26185121](https://pubmed.ncbi.nlm.nih.gov/26185121)\] 92. Savukoski T, Engström E, Engblom J, Ristiniemi N, Wittfooth S, Lindahl B, Eggers KM, Venge P, Pettersson K. Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. Clin Chem. 2012 Jun;58(6):1040-8. \[[PubMed: 22490617](https://pubmed.ncbi.nlm.nih.gov/22490617)\] 93. Bayoumy S, Martiskainen I, Heikkilä T, Rautanen C, Hedberg P, Hyytiä H, Wittfooth S, Pettersson K. Sensitive and quantitative detection of cardiac troponin I with upconverting nanoparticle lateral flow test with minimized interference. Sci Rep. 2021 Sep 21;11(1):18698. \[[PMC free article: PMC8455528](/pmc/articles/PMC8455528/)\] \[[PubMed: 34548577](https://pubmed.ncbi.nlm.nih.gov/34548577)\] 94. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem. 2005 May;51(5):839-47. \[[PubMed: 15718489](https://pubmed.ncbi.nlm.nih.gov/15718489)\] 95. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD., Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. \[[PubMed: 30153967](https://pubmed.ncbi.nlm.nih.gov/30153967)\] 96. Westwood M, Ramaekers B, Grimm S, Worthy G, Fayter D, Armstrong N, Buksnys T, Ross J, Joore M, Kleijnen J. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation. Health Technol Assess. 2021 May;25(33):1-276. \[[PMC